Hemodialysis Catheter Infection
12
0
1
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
16.7%
2 terminated out of 12 trials
71.4%
-15.1% vs benchmark
33%
4 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial
Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)
Evaluation of the Impact of the UPLUG Device Onto the Infection Rate of Indwelling Central Venous Catheters in Patients Undergoing Chronic Hemodialysis
The Pristine Post-Market Study
Chlorhexidine Dressings for Hemodialysis Catheter Exit Site Care: Comparative Study
Mupirocin 2% Ointment Vs Spray Antibiotics on Temporary Hemodialysis Catheter
Evaluation of the Efficacy of Prophylactic Topical Gentamicin in Tunnelled Catheters for Hemodialysis
Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients
Neutrolin Versus Heparin for Locking Hemodialysis Catheters
Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters.
Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients